Industry Milestone: Over 15,000 Studies Have Run on Medidata Cloud Platform

Medidata Enables Digital Transformation in Life Sciences with Largest
Data Repository, Powered by AI and Advanced Analytics

News Summary


  • Industry adoption leads to rapid growth of the Medidata Cloud, now
    with over 15,000 studies worldwide, spanning all clinical phases
    and therapeutic areas
  • Over 100,000 life science professionals are certified on the
    Medidata platform and over 2 million eLearning courses completed
    since 2010
  • Medidata enables customers to make data-driven decisions in real time
    by applying AI and advanced analytics to the industry’s largest, most
    comprehensive data repository, with more than 4.4 million patients

Industry’s Largest Ecosystem and Unparalleled Expertise Accelerate
Clinical Research

NEW YORK–(BUSINESS WIRE)–#MDSO–More than 15,000 studies have been conducted on the Medidata Cloud, the
Intelligent Platform for Life Sciences, Medidata (NASDAQ: MDSO)
announced today, making it the industry’s largest data repository.

Ranked as the global leader in life science development software revenue1,
this milestone highlights the company’s position and experience in the
market.

Building upon the most comprehensive data assets in clinical research,
Medidata applies artificial intelligence and advanced analytics to
deliver meaningful insights to over 1,000
customers
across every therapeutic area and clinical phase. More
than 100,000 professionals are certified on Medidata’s platform, and
over two million eLearning courses have been completed since 2010.

MEDS & AI: Powering Intelligent Clinical Trials for Sponsors and CROs

The velocity and variety of data is accelerating in clinical trials,
making integration and standardization more complex than ever before. To
solve for this, Medidata created the Medidata
Enterprise Data Store (MEDS
), the largest clinical data repository
with more than 4.4 million patients. Powered by AI, MEDS leverages
innovative technologies to streamline labor intensive steps and improve
decision making in the design, execution and review of clinical trials.

Over 100 Medidata data scientists, including former FDA statisticians,
designed the Medidata AI framework to optimize the value of data through
advanced machine learning, predictive models and natural-language
processing. MEDS & AI provide important new insights to clinicians and
decision makers in clinical operations, biostatistics, and data
management. Among the benefits:

  • Improve data quality and reduce timelines and regulatory risk
    using machine learning that automates detection of problematic data
    points
  • Optimize protocol design with data-driven insights from
    thousands of historical clinical trials
  • Better inform go/no-go decisions with Medidata Synthetic
    Control Arms that utilize aggregated data from previous clinical trials
  • Discover biomarkers with machine learning that mines big data
    sources
  • Boost signal detection with proprietary algorithms trained with
    millions of data points

“Our innovative technology, services and data-driven insights are
unmatched in life sciences, allowing us to achieve this significant
industry milestone,” said Tarek Sherif, chairman and chief executive
officer, Medidata. “We built the largest repository of clinical data and
maximize its value through AI and analytics, to lead digital
transformation within our industry.”

“With the life science industry under strong pressure to more quickly
and efficiently bring new drugs to market, the clinical trial ecosystem
is rapidly evolving and expanding. Medidata is continuing to
aggressively invest in growth by strengthening interoperability, adding
new capabilities, and expanding access to their platform,” says Alan S.
Louie, Ph.D., research director, life sciences, IDC Health Insights.

Learn more about the Medidata Cloud. Join over 1,000 life science
leaders at NEXT
NYC
on October 24-25. Register
today
.

1IDC, Worldwide Life Science Software Market Shares, 2017:
Strong, Aggressive Growth Driving Change at the Top, doc #US43964017,
June 2018

About Medidata

Medidata is leading the digital transformation of life sciences with the
world’s most-used platform for clinical development, commercial and
real-world data. Powered by artificial intelligence and delivered by #1
ranked industry experts, the Intelligent Platform for Life Sciences
helps pharmaceutical, biotech, medical device companies and academic
researchers accelerate value, minimize risk and optimize outcomes.
Medidata serves more than 1,000 customers and partners worldwide and
empowers more than 100,000 certified users everyday to create hope for
millions of patients. Discover the future of life sciences: www.mdsol.com

Contacts

Investors:
Betsy Frank, 917-522-4620
bfrank@mdsol.com
or
Media:
Erik
Snider, 646-362-2997
esnider@mdsol.com

leverton

I have been involved with publishing and marketing for the past 32 years. My passion is helping people share their voice. I am able to do this through two important venues: One, with Area-Info.net where people can share everything from opinions to events to news. It is your choice! What do you want to share? Two, through a new program called America's Real Deal I am involved with to help business owners get their voice heard.I schedule speaking engagements with community groups and business groups to share my passion about the importance of "sharing your voice".Contact me directly at lee@leeeverton.coom for scheduling information.